NEUROCRINE BIOSCIENCES INC Accrued Income Taxes, Current
NEUROCRINE BIOSCIENCES INC (NBIX) had Accrued Income Taxes, Current of $114.60 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-07-31
- 2026-06-30: Accrued Income Taxes, Current $114.60M.
- 2026-03-31: Accrued Income Taxes, Current $186.40M.
- 2025-12-31: Accrued Income Taxes, Current $68.00M.
- 2025-06-30: Accrued Income Taxes, Current $25.70M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $114.60M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $186.40M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $68.00M 10-Q · filed 2026-07-31 |
| 2025-06-30 | $25.70M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $25.40M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $10.00M 10-K · filed 2026-02-11 |
| 2024-03-31 | $24.80M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $24.40M 10-Q · filed 2024-05-01 |
| 2023-09-30 | $72.70M 10-Q · filed 2023-10-31 |
| 2022-12-31 | $9.00M 10-K · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |